Domperidone Protects Cells from Intoxication with Clostridioides difficile Toxins by Inhibiting Hsp70-Assisted Membrane Translocation
暂无分享,去创建一个
H. Barth | Mary Elias Kamel Wahba | P. Papatheodorou | Katharina Ernst | J. Schmid | Jinfang Jia | Maria Braune-Yan
[1] Katharina Ernst. Requirement of Peptidyl-Prolyl Cis/Trans isomerases and chaperones for cellular uptake of bacterial AB-type toxins , 2022, Frontiers in Cellular and Infection Microbiology.
[2] H. Mikamo,et al. Risk factors of first recurrence of Clostridioides difficile infection. , 2022, Anaerobe.
[3] M. Frick,et al. Inhibition of Clostridioides difficile Toxins TcdA and TcdB by Ambroxol , 2022, Frontiers in Pharmacology.
[4] D. Lacy,et al. Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics , 2021, Nature Reviews Microbiology.
[5] J. Harper,et al. Proline Isomerization as a Key Determinant for Hsp90-Toxin Interactions , 2021, Frontiers in Cellular and Infection Microbiology.
[6] K. Garey,et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[7] R. Godoy-Ruiz,et al. The Importance of Therapeutically Targeting the Binary Toxin from Clostridioides difficile , 2021, International journal of molecular sciences.
[8] K. Filion,et al. Domperidone and the risks of sudden cardiac death and ventricular arrhythmia: A systematic review and meta‐analysis of observational studies , 2021, British journal of clinical pharmacology.
[9] D. di Bernardo,et al. Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B. , 2020, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Barth,et al. Intoxication of mammalian cells with binary clostridial enterotoxins is inhibited by the combination of pharmacological chaperone inhibitors , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.
[11] M. Frick,et al. Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo , 2020, bioRxiv.
[12] A. Shen. Clostridioides difficile Spores: Bile Acid Sensors and Trojan Horses of Transmission , 2020, Clinics in Colon and Rectal Surgery.
[13] T. Banerjee,et al. A binding motif for Hsp90 in the A chains of ADP‐ribosylating toxins that move from the endoplasmic reticulum to the cytosol , 2019, Cellular microbiology.
[14] Nadinath B. Nillegoda,et al. The Hsp70 chaperone network , 2019, Nature Reviews Molecular Cell Biology.
[15] S. Tatulian,et al. HSC70 and HSP90 chaperones perform complementary roles in translocation of the cholera toxin A1 subunit from the endoplasmic reticulum to the cytosol , 2019, The Journal of Biological Chemistry.
[16] H. Barth,et al. Combined Pharmacological Inhibition of Cyclophilins, FK506-Binding Proteins, Hsp90, and Hsp70 Protects Cells From Clostridium botulinum C2 Toxin , 2018, Front. Pharmacol..
[17] A. Schlosser,et al. The chaperonin TRiC/CCT is essential for the action of bacterial glycosylating protein toxins like Clostridium difficile toxins A and B , 2018, Proceedings of the National Academy of Sciences.
[18] Stuart Johnson,et al. Bezlotoxumab , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[19] H. Barth,et al. Pharmacological Cyclophilin Inhibitors Prevent Intoxication of Mammalian Cells with Bordetella pertussis Toxin , 2018, Toxins.
[20] M. Fauler,et al. Hsp70 facilitates trans-membrane transport of bacterial ADP-ribosylating toxins into the cytosol of mammalian cells , 2017, Scientific Reports.
[21] J. Buchner,et al. The Hsp90 machinery facilitates the transport of diphtheria toxin into human cells , 2017, Scientific Reports.
[22] David Balchin,et al. In vivo aspects of protein folding and quality control , 2016, Science.
[23] H. Ihmels,et al. A novel Hsp70 inhibitor prevents cell intoxication with the actin ADP-ribosylating Clostridium perfringens iota toxin , 2016, Scientific Reports.
[24] Andrija Finka,et al. Multi-layered molecular mechanisms of polypeptide holding, unfolding and disaggregation by HSP70/HSP110 chaperones , 2015, Front. Mol. Biosci..
[25] L. Gierasch,et al. How hsp70 molecular machines interact with their substrates to mediate diverse physiological functions. , 2015, Journal of molecular biology.
[26] J. Michaelis,et al. Cyclophilin-facilitated membrane translocation as pharmacological target to prevent intoxication of mammalian cells by binary clostridial actin ADP-ribosylated toxins. , 2015, Journal of molecular biology.
[27] Philip F. Hughes,et al. Identification of an allosteric small-molecule inhibitor selective for the inducible form of heat shock protein 70. , 2014, Chemistry & biology.
[28] S. Tatulian,et al. Co- and Post-translocation Roles for HSP90 in Cholera Intoxication* , 2014, The Journal of Biological Chemistry.
[29] N. Minton,et al. University of Birmingham Importance of Toxin A, Toxin B, and CDT in virulence of an epidemic Clostridium difficile strain , 2013 .
[30] K. Aktories,et al. FK506‐binding protein 51 interacts with Clostridium botulinum C2 toxin and FK506 inhibits membrane translocation of the toxin in mammalian cells , 2012, Cellular microbiology.
[31] Johannes Buchner,et al. Membrane Translocation of Binary Actin-ADP-Ribosylating Toxins from Clostridium difficile and Clostridium perfringens Is Facilitated by Cyclophilin A and Hsp90 , 2011, Infection and Immunity.
[32] Johannes Buchner,et al. Role of CypA and Hsp90 in membrane translocation mediated by anthrax protective antigen , 2011, Cellular microbiology.
[33] K. Teter,et al. Hsp90 Is Required for Transfer of the Cholera Toxin A1 Subunit from the Endoplasmic Reticulum to the Cytosol* , 2010, The Journal of Biological Chemistry.
[34] Constantinos Zamboglou,et al. Clostridial Glucosylating Toxins Enter Cells via Clathrin-Mediated Endocytosis , 2010, PloS one.
[35] H. Barth,et al. Cyclophilin A facilitates translocation of the Clostridium botulinum C2 toxin across membranes of acidified endosomes into the cytosol of mammalian cells , 2009, Cellular microbiology.
[36] M. Drysdale,et al. Novel adenosine-derived inhibitors of 70 kDa heat shock protein, discovered through structure-based design. , 2009, Journal of medicinal chemistry.
[37] M. Gerstein,et al. Defining the TRiC/CCT interactome links chaperonin function to stabilization of newly-made proteins with complex topologies , 2008, Nature Structural &Molecular Biology.
[38] G. Schulz,et al. Inhibition of the glucosyltransferase activity of clostridial Rho/Ras‐glucosylating toxins by castanospermine , 2008, FEBS letters.
[39] Klaus Aktories,et al. Auto-catalytic Cleavage of Clostridium difficile Toxins A and B Depends on Cysteine Protease Activity* , 2007, Journal of Biological Chemistry.
[40] R. McCallum,et al. Domperidone: Review of Pharmacology and Clinical Applications in Gastroenterology , 2007, The American Journal of Gastroenterology.
[41] S. Tenzer,et al. Autocatalytic cleavage of Clostridium difficile toxin B , 2007, Nature.
[42] K. Aktories,et al. Cellular Uptake of Clostridium difficile Toxin B , 2003, Journal of Biological Chemistry.
[43] Dirk Tiemann,et al. The Host Cell Chaperone Hsp90 Is Essential for Translocation of the Binary Clostridium botulinum C2 Toxin into the Cytosol* , 2003, Journal of Biological Chemistry.
[44] A. Hall,et al. Rho GTPases in cell biology , 2002, Nature.
[45] R. Benz,et al. Low pH-induced Formation of Ion Channels by Clostridium difficile Toxin B in Target Cells* , 2001, The Journal of Biological Chemistry.
[46] R. Benz,et al. Cellular Uptake of Clostridium botulinum C2 Toxin Requires Oligomerization and Acidification* , 2000, The Journal of Biological Chemistry.
[47] J. Ballard,et al. pH-Induced Conformational Changes inClostridium difficile Toxin B , 2000, Infection and Immunity.
[48] M. Wilm,et al. The Enterotoxin from Clostridium difficile (ToxA) Monoglucosylates the Rho Proteins(*) , 1995, The Journal of Biological Chemistry.
[49] M. Mann,et al. Glucosylation of Rho proteins by Clostridium difficile toxin B , 1995, Nature.
[50] C. von Eichel-Streiber,et al. Purification of two high molecular weight toxins of Clostridium difficile which are antigenically related. , 1987, Microbial pathogenesis.
[51] Matthew Sims,et al. Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. , 2017 .